[Hematologic manifestations of cancers of the prostate].
Authors study six cases of prostatic adenocarcinoma with bone marrow metastatic involvement. Hematological manifestations can be: intravascular coagulation with anemia and myelemia. The heparin permits to control the intravascular coagulation when waiting the effect of hormonotherapy, chemotherapy or radiotherapy.
D000230:Adenocarcinoma / Q000097:blood / Q000150:complications* / Q000556:secondary; D001706:Biopsy; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000209:etiology; D001853:Bone Marrow / Q000473:pathology; D001855:Bone Marrow Diseases / Q000473:pathology; D006402:Hematologic Diseases / Q000209:etiology*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000150:complications*
Manifestations hématologiques des cancers de la prostate.